Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health

CN Fries, EJ Curvino, JL Chen, SR Permar… - Nature …, 2021 - nature.com
Despite the overwhelming success of vaccines in preventing infectious diseases, there
remain numerous globally devastating diseases without fully protective vaccines, particularly …

Of tuberculosis and non-tuberculous mycobacterial infections–a comparative analysis of epidemiology, diagnosis and treatment

R Gopalaswamy, S Shanmugam, R Mondal… - Journal of biomedical …, 2020 - Springer
Pulmonary diseases due to mycobacteria cause significant morbidity and mortality to human
health. In addition to tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), recent …

Next-generation TB vaccines: progress, challenges, and prospects

L Zhuang, Z Ye, L Li, L Yang, W Gong - Vaccines, 2023 - mdpi.com
Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), is a prevalent global
infectious disease and a leading cause of mortality worldwide. Currently, the only available …

[HTML][HTML] Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis

TJ Scriba, MG Netea, AM Ginsberg - Seminars in immunology, 2020 - Elsevier
Tuberculosis is the leading infectious disease killer globally due to a single pathogen.
Despite wide deployment of standard drug regimens, modern diagnostics and a vaccine …

New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia

R Tarancón, J Domínguez-Andrés, S Uranga… - PLoS …, 2020 - journals.plos.org
Among infectious diseases, tuberculosis is the leading cause of death worldwide, and
represents a serious threat, especially in developing countries. The protective effects of …

Immunotherapies against human bacterial and fungal infectious diseases: A review

H Qadri, AH Shah, M Alkhanani, A Almilaibary… - Frontiers in …, 2023 - frontiersin.org
Nations' ongoing struggles with a number of novel and reemerging infectious diseases,
including the ongoing global health issue, the SARS-Co-V2 (severe acute respiratory …

Update on TB vaccine pipeline

C Martin, N Aguilo, D Marinova, J Gonzalo-Asensio - Applied Sciences, 2020 - mdpi.com
In addition to antibiotics, vaccination is considered among the most efficacious methods in
the control and the potential eradication of infectious diseases. New safe and effective …

BCG‐induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next‐generation vaccines

M Foster, PC Hill, TP Setiabudiawan… - Immunological …, 2021 - Wiley Online Library
The tuberculosis (TB) vaccine Bacillus Calmette‐Guérin (BCG) was introduced 100 years
ago, but as it provides insufficient protection against TB disease, especially in adults, new …

Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection

K Dijkman, N Aguilo, C Boot, SO Hofman… - Cell Reports …, 2021 - cell.com
To fight tuberculosis, better vaccination strategies are needed. Live attenuated
Mycobacterium tuberculosis-derived vaccine, MTBVAC, is a promising candidate in the …

Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections

M Moreno-Molina, N Shubladze, I Khurtsilava… - Nature …, 2021 - nature.com
Polyclonal infections occur when at least two unrelated strains of the same pathogen are
detected in an individual. This has been linked to worse clinical outcomes in tuberculosis, as …